...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New shares issued?

My brokerage continues to recognize Zenith shares as having a value of $0.657.

Given the value of the recent placement, there should be opportunity in tax planning with Zenith shares.

I had previously transferred some to my RRSP. I don’t have much room left there.

I’m wondering what others are doing.

My TFSA is currently full. I’d have to sell TFSA holdings to create room in that account.

Given the value discrepancy to the recent privately sold shares, this might be a smart thing to do.

 

bfw

Share
New Message
Please login to post a reply